Intercept Pharmaceuticals (ICPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55,860 | 92,828 | 65,654 | 74,780 | 43,248 |
| Marketable Securities | 435,049 | 334,980 | 411,516 | 582,567 | 392,912 |
| Receivables | 26,862 | 28,337 | 41,549 | 38,044 | 25,694 |
| Other current assets | 0 | 29,095 | 0 | 0 | 0 |
| TOTAL | $540,127 | $508,018 | $545,741 | $721,315 | $482,425 |
| Non-Current Assets | |||||
| PPE Net | 987 | 3,281 | 6,326 | 5,202 | 10,411 |
| Other Non-Current Assets | 12,597 | 15,724 | 28,422 | 28,369 | 16,331 |
| TOTAL | $13,584 | $19,005 | $34,748 | $33,571 | $26,742 |
| Total Assets | $553,711 | $527,023 | $580,489 | $754,886 | $509,167 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 109,569 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 116,977 | 103,780 | 171,039 | 153,968 | 105,109 |
| TOTAL | $230,077 | $168,161 | $179,076 | $162,005 | $114,205 |
| Non-Current Liabilities | |||||
| Long Term Debt | 223,104 | 539,782 | 560,582 | 532,078 | 371,250 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 1,621 |
| Other Non-Current Liabilities | 7,453 | 3,042 | 7,684 | 9,247 | 3,771 |
| TOTAL | $230,557 | $542,824 | $568,266 | $541,325 | $375,832 |
| Total Liabilities | $460,634 | $710,985 | $747,342 | $703,330 | $490,037 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41,670 | 29,693 | 33,016 | 32,853 | 29,694 |
| Common Shares | 42 | 30 | 33 | 33 | 30 |
| Retained earnings | -2,136,888 | -2,489,772 | -2,398,346 | -2,123,466 | -1,778,785 |
| Other shareholders' equity | -8,256 | -2,873 | -2,477 | -1,144 | -2,259 |
| TOTAL | $93,077 | $-183,962 | $-166,853 | $51,556 | $19,130 |
| Total Liabilities And Equity | $553,711 | $527,023 | $580,489 | $754,886 | $509,167 |